Glycopyrrolate for clozapine-induced sialorrhea.
Duggal
Harpreet S
HS
D000328:Adult; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D005476:Fluphenazine / Q000627:therapeutic use; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced* / Q000188:drug therapy*; D014635:Valproic Acid / Q000627:therapeutic use
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D014635:Valproic Acid; D003024:Clozapine; D005476:Fluphenazine; D006024:Glycopyrrolate